Straits Times Index
3,322.18 -4.10 (-0.12%) Nikkei
39,667.07 +493.92 (+1.26%) Hang Seng
18,123.62 +50.72 (+0.28%) FTSE 100
8,247.79 -33.76 (-0.41%) Bitcoin USD
61,622.19 +561.33 (+0.92%) CMC Crypto 200
1,279.10 -4.69 (-0.37%)
Solventum Corporation (SOLV)
After hours:
| Previous close | 51.30 |
| Open | 51.24 |
| Bid | 51.08 x 1000 |
| Ask | 51.60 x 1000 |
| Day's range | 50.63 - 51.62 |
| 52-week range | 50.63 - 72.40 |
| Volume | |
| Avg. volume | 2,526,440 |
| Market cap | 8.851B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Solventum introduces denials prevention solution, an AI-powered tool, empowering health systems to help reduce write-offs and improve top line revenue
Solventum (NYSE: SOLV), [formerly 3M Health Care] today announced a new artificial intelligence (AI)-driven payment integrity and revenue cycle solution, Solventum™ Revenue Integrity System. In collaboration with Sift Healthcare, this solution is designed to help health systems not only reduce potential denials but prevent them and ensure timely and accurate payer reimbursement.
- PR Newswire
Solventum Cautions Investors Regarding TRC Capital's "Mini-Tender Offer"
Solventum (NYSE: SOLV) has been notified that TRC Capital Investment Corporation ("TRC") made an unsolicited "mini-tender offer" to purchase up to 2,000,000 shares of the company's common stock at $59.15 per share and decreased the offer price on June 6, 2024, to $55.00 per share. The closing stock price of Solventum's common stock on June 6, 2024 was $55.05.
- PR Newswire
Solventum Reports First Quarter 2024 Financial Results and Capital Allocation Update
Solventum (NYSE: SOLV) today reported carve-out financial results for the first quarter ended March 31, 2024.
